Explore Biotech Companies

Quotient Therapeutics pioneers somatic genomics, creating a genetic library to develop therapies for various diseases using genomics, AI, and automation.

📍 Cambridge, MA

Quiver Bioscience develops precision genetic medicines for brain disorders using human disease models and AI.

📍 Cambridge, MA

Quantori provides digital transformation, AI, and data science solutions for life sciences and healthcare, accelerating drug discovery and delivery.

📍 Cambridge, MA

ProQR Therapeutics is a Dutch biotech company developing oligonucleotide and RNA therapies for severe rare and common genetic diseases using its proprietary Axiomer platform.

📍 Cambridge, MA

ProMIS Neurosciences is a clinical-stage biotech company developing antibody therapies targeting toxic proteins in neurodegenerative diseases like Alzheimer's and ALS.

📍 Cambridge, MA

PROMETRIKA is a full-service CRO founded in 2003, offering data management, biostatistics, and medical writing for pharma/biotech.

📍 Cambridge, MA

ProFound Therapeutics discovers novel proteins in the expanded human proteome to create new drugs and therapeutic targets.

📍 Cambridge, MA

Prime Medicine uses Prime Editing, a gene editing technology that can "search and replace" to treat debilitating genetic diseases.

📍 Cambridge, MA

Pramana is a biotech company revolutionizing pathology labs with autonomous digital pathology systems and whole slide imaging, focusing on cardiometabolic diseases.

📍 Cambridge, MA

Portal Instruments is a MedTech company developing a needle-free drug delivery platform for biologics, founded out of MIT.

📍 Cambridge, MA

PineTree Therapeutics is an award-winning, pre-clinical biotech company developing novel antibody-based targeted protein degraders for oncology.

📍 Cambridge, MA

Pending AI offers an AI and quantum mechanics drug discovery platform for creating new medicines.

📍 Cambridge, MA

Pearl Bio leverages synthetic biology and genome engineering to create novel 'smart biologics' and biomaterials for advanced therapeutics.

📍 Cambridge, MA

Paraza Pharma offers integrated drug discovery services with in-house Chemistry, Biology, and DMPK expertise, acting as an extension of client teams.

📍 Cambridge, MA

Parallel Biosystems uses human immune organoids and AI for drug discovery, aiming to replace animal testing with a human-first platform.

📍 Cambridge, MA

Parabilis Medicines is a clinical-stage biopharmaceutical company developing cell-penetrating miniproteins and ultra-tunable peptide therapeutics for severe diseases, particularly cancer.

📍 Cambridge, MA

Oryzon Genomics is a clinical-stage biopharmaceutical company focused on epigenetic personalized medicines for cancer and CNS disorders, including biomarker identification and drug development.

📍 Cambridge, MA

Orbital Therapeutics pioneers RNA medicines, including in vivo CAR-T therapies, to treat disease at its source and enhance global health.

📍 Cambridge, MA

Nuvalent is a clinical-stage biopharmaceutical company focused on developing precisely targeted, structure-based small molecule therapies for kinase targets in cancer.

📍 Cambridge, MA

NS Pharma is a research-driven biopharmaceutical company focused on rare diseases, developing life-changing therapies and small molecule treatments.

📍 Paramus, NJ

NovoBiotic Pharmaceuticals is an early-stage biotech company focused on discovering new drugs from previously unculturable microorganisms found in nature.

📍 Cambridge, MA

Novaliq is a pharmaceutical company specializing in drug delivery for ocular therapeutics using their proprietary EyeSol® technology.

📍 Cambridge, MA

nference is a clinical AI company using multimodal AI agents and real-world data to personalize care and accelerate precision research and drug development.

📍 Cambridge, MA

NextPoint Therapeutics develops precision immuno-oncology therapeutics, including antibody-drug conjugates, targeting the novel B7-H7/HHLA2 axis.

📍 Cambridge, MA